New marker for tumor aggression in neurofibromatosis type 1
Author: Johns Hopkins Medicine
Published On: 10/16/19
A new study of tumor samples from people with the rare genetic syndrome neurofibromatosis type 1 (NF1) has uncovered novel molecular clues about which tumors are most likely to be aggressive in those with NF1. According to the researchers, the clues could advance the search for more customized and relevant treatments that spare patients exposure to treatments unlikely to work.
Read more here.